Friday 6 November 2026 Export DVA’s income statement to Excel — free account

DaVita Inc.

DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024.

Revenue: +4.62%
EPS: +67.0%
Free cash flow: −45.8%
Total debt: +5.07%

Quarter to September 2026, against a year earlier

189.72 5.10 −2.62%

Follow DVA

Alert me

Market cap: $12.3B
P/E: 14.0×
Fwd P/E: 13.0×
Dividend yield: —
F-score: 6/9
Altman Z: 1.49
Beneish M: −2.59
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

DaVita Inc. (DVA) revenue by segment, product and region

Where the money comes from and where it goes

Fiscal 2025: revenue by segment, and margins
U. S. Dialysis And Related Lab Services	11,732	85.99%
Other - Ancillary Services	1,911	14.01%
Gross margin		32.25%
Operating margin		14.98%
Pre-tax margin		9.87%

Revenue by segment $m

Line	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
U. S. Dialysis And Related Lab Services	11,732 85.99%	11,319 88.32%	10,849 89.36%	—	10,667 91.81%	10,660 92.29%	10,563 92.75%	10,336 90.63%	9,360 86.06%	9,111 85.09%
Other - Ancillary Services	1,911 14.01%	1,497 11.68%	1,291 10.64%	—	1,043 8.97%	1,036 8.97%	958 8.41%	1,196 10.49%	1,596 14.68%	1,597 14.91%
Also reported: a second breakdown of the same revenue
U S Dialysis And Related Lab Services with Intersegment	11,793 86.44%	11,391 88.88%	10,937 90.09%	10,600 91.30%	—	—	—	—	—	—
Other Operating Segments with Intersegment	1,922 14.09%	1,510 11.79%	1,299 10.70%	1,101 9.49%	—	—	—	—	—	—
Eliminations	—	—	—	(91) (0.79%)	(91) (0.78%)	(145) (1.26%)	(132) (1.16%)	(127) (1.12%)	(80) (0.73%)	—
Revenue	13,643	12,816	12,140	11,610	11,619	11,551	11,388	11,405	10,877	10,707

Operating income by segment $m, and margin

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
U. S. Dialysis And Related Lab Services	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Other - Ancillary Services	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Corporate and other	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Operating income	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

Operating figures as reported in each quarter’s results release or filing

Figure	Quarter	Latest	A year before	Change
Annualized medical spend	Q2 FY2026	$5.8B	$5.3B	+9.43%
Average patient service revenue per treatment	Q3 FY2026	$415.25	$410.59	+1.13%
Average treatments per day	Q3 FY2026	92.8K	91.7K	+1.20%
Average treatments per normalized day	Q3 FY2026	92.5K	—	—
Depreciation and amortization expense per treatment	Q3 FY2026	$19.70	$21.57	−8.67%
DSO	Q3 FY2026	51.00	53.00	−3.77%
General and administrative expenses per treatment	Q3 FY2026	$43.14	$44.51	−3.08%
International outpatient dialysis centers	Q3 FY2026	598.00	585.00	+2.22%
Number of normalized treatment days	Q3 FY2026	79.20	—	—
Number of treatment days	Q3 FY2026	79.00	79.0M	−100.00%
Outpatient dialysis centers	Q3 FY2026	3.3K	3.2K	+0.68%
Patient care costs per treatment	Q3 FY2026	$280.22	$273.54	+2.44%
Patients	Q3 FY2026	298.1K	293.2K	+1.67%
Patients in other integrated care arrangements	Q3 FY2026	3.1K	—	—
Patients in risk-based integrated care arrangements	Q3 FY2026	80.8K	64.9K	+24.50%
Per day increase	Q3 FY2026	0.10%	—	—
Treatments	Q3 FY2026	7.3M	7.2M	+1.20%
U.S. outpatient dialysis centers	Q3 FY2026	2.7K	2.7K	+0.34%

	Q3 FY2026	Q2 FY2026	Q1 FY2026	Q4 FY2025	Q3 FY2025	Q2 FY2025	Q1 FY2025	Q4 FY2024	Q3 FY2024	Q2 FY2024	Q1 FY2024	Q4 FY2023	Q3 FY2023
Annualized medical spend	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Average patient service revenue per treatment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Average treatments per day	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Average treatments per normalized day	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Depreciation and amortization expense per treatment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
DSO	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
General and administrative expenses per treatment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
International outpatient dialysis centers	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Number of normalized treatment days	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Number of treatment days	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Outpatient dialysis centers	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Patient care costs per treatment	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Patients	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Patients in other integrated care arrangements	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Patients in risk-based integrated care arrangements	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Per day increase	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
Treatments	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡
U.S. outpatient dialysis centers	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡	‡

As each company reports them in its 10-K and 10-Q filings, in US dollars. Where a later filing recast a year's segments, the year is shown as recast; a period whose breakdown does not add up to the company's revenue is left out.